This inventor holds 1 USPTO granted patent. Top assignees: Smartin Bio Inc., Ulsan National Institute of Science and Technology. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 343 Years Active: 2026
Title: Changwook Lee: Innovator in Neovascularization Research
Introduction
Changwook Lee is a prominent inventor based in Ulsan, South Korea. He has made significant contributions to the field of biomedical research, particularly in the area of neovascularization. His work focuses on developing compounds that can inhibit factors associated with neovascularization diseases.
Latest Patents
Changwook Lee holds 1 patent for his invention titled "Compounds for inhibiting neovascularization factors and use thereof." This patent details compounds designed to inhibit neovascularization factors and outlines methods for treating diseases related to neovascularization using these compounds.
Career Highlights
Throughout his career, Changwook Lee has worked with notable organizations, including Smartin Bio Inc. and the Ulsan National Institute of Science and Technology. His experience in these institutions has allowed him to advance his research and contribute to innovative solutions in the medical field.
Collaborations
Changwook Lee has collaborated with esteemed colleagues, including Byoung Heon Kang and Nam Gu Yoon. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic approaches.
Conclusion
Changwook Lee's innovative work in the field of neovascularization research exemplifies his commitment to advancing medical science. His contributions through patents and collaborations highlight the importance of innovation in addressing complex health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile